- Review
Liquid Biopsy in Pancreatic Ductal Adenocarcinoma: Clinical Utility, Trials, and Future Directions
- Ahmed Bendari,
- Oana Vele,
- Brett Baskovich,
- Alaa Bendari,
- Mona Sebika,
- Juan Luis Gomez Marti,
- Kritika Krishnamurthy and
- Saeed Asiry
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy marked by late diagnosis, rapid progression, and poor prognosis, with a 5-year survival rate of 2–9%. Traditional tissue biopsy faces limitations in accessibility and real-time moni...

